Clarus Group Inc. Has $739,000 Position in Chemed Co. (NYSE:CHE)

Clarus Group Inc. lowered its holdings in Chemed Co. (NYSE:CHE) by 7.4% during the fourth quarter, Holdings Channel.com reports. The firm owned 1,395 shares of the company’s stock after selling 111 shares during the period. Clarus Group Inc.’s holdings in Chemed were worth $739,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of CHE. International Assets Investment Management LLC acquired a new position in Chemed in the third quarter worth $437,150,000. FMR LLC boosted its stake in Chemed by 23.8% in the third quarter. FMR LLC now owns 238,616 shares of the company’s stock worth $143,401,000 after purchasing an additional 45,917 shares in the last quarter. Thrivent Financial for Lutherans boosted its stake in Chemed by 25.3% in the third quarter. Thrivent Financial for Lutherans now owns 146,017 shares of the company’s stock worth $87,752,000 after purchasing an additional 29,445 shares in the last quarter. Aureus Asset Management LLC boosted its stake in Chemed by 3,147.2% in the third quarter. Aureus Asset Management LLC now owns 29,939 shares of the company’s stock worth $17,993,000 after purchasing an additional 29,017 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its stake in Chemed by 143.5% in the third quarter. Allspring Global Investments Holdings LLC now owns 42,267 shares of the company’s stock worth $25,401,000 after purchasing an additional 24,912 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on CHE shares. Royal Bank of Canada dropped their target price on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research report on Tuesday, November 5th. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th.

Chemed Stock Up 0.6 %

CHE stock opened at $553.44 on Tuesday. The company has a market cap of $8.33 billion, a P/E ratio of 27.97, a PEG ratio of 2.16 and a beta of 0.48. Chemed Co. has a twelve month low of $512.12 and a twelve month high of $654.62. The business has a fifty day moving average of $542.91 and a 200-day moving average of $564.81.

Insider Transactions at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $572.77, for a total value of $1,145,540.00. Following the completion of the sale, the chief executive officer now owns 101,735 shares in the company, valued at approximately $58,270,755.95. This represents a 1.93 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, VP Brian C. Judkins acquired 145 shares of the company’s stock in a transaction that occurred on Monday, December 30th. The stock was bought at an average price of $519.50 per share, with a total value of $75,327.50. Following the acquisition, the vice president now directly owns 1,678 shares of the company’s stock, valued at $871,721. The trade was a 9.46 % increase in their position. The disclosure for this purchase can be found here. 3.32% of the stock is currently owned by corporate insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.